Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial

Name: Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Published: 2028
License: Public Domain

XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · 2028

ClinicalTrials.gov · Datasets · License: Public Domain · 2028

Open Source ↗

clinical-trial efficacy induced-pluripotent-stem-cells rct safety spinal-cord-injury transplantation

spinal cord injury, safety, efficacy, clinical trial, induced pluripotent stem cells, human motor neuron progenitor, transplantation, rct, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial

Related documents